Advertisement
Screener

Nabriva Therapeutics plc Stockholders' Equity Attributable to Noncontrolling Interest

Nabriva Therapeutics plc Stockholders' Equity Attributable to Noncontrolling Interest

Nabriva Therapeutics plc had Stockholders' Equity Attributable to Noncontrolling Interest of $710.00 thousand as of 2017-06-30, per its 10-Q filed 2017-08-07.

Discontinued › Balance Sheet › Equity › Equity, Including Portion Attributable to Noncontrolling Interest

us-gaap:MinorityInterest · last filed 2017-08-07

  • 2017-06-30: Stockholders' Equity Attributable to Noncontrolling Interest $710.00K.
Period endStockholders' Equity Attributable to Noncontrolling Interest
2017-06-30$710.00K
10-Q · filed 2017-08-07